University of Cambridge portfolio company Astex Pharmaceuticals is to be acquired by a Japanese company in order to accelerate the development of new cancer treatments.

Natural ventilation technology which has the potential to reduce heating bills by as much as 50%, while drastically reducing energy consumption, has been developed by a Cambridge spin-out.

Ultra-light, high performance electrical wiring, made from carbon instead of copper, has been developed in a usable form for the first time.

Cambridge researchers developing new therapies as part of a collaborative programme with industry.

New Cambridge spin-out raises $11 million in funding to develop revolutionary new drug for thrombosis, which causes heart attacks and strokes.

A new simulator could help the elderly or disabled users engage more effectively with electronic devices, including websites, smartphones and digital television.

A synthetic material which mimics the brightest and most vivid colours in nature, and changes colour when twisted or stretched, has been developed by researchers at the University of Cambridge, and could have important applications in the security, textile and sensing industries.

A new report suggests that global production shift to Asia may have “run its course” and points to “undervalued” mid-sized manufacturing firms as essential to UK economic regrowth

A range of diseases and conditions, from asthma to liver disease, could be diagnosed and monitored quickly and painlessly just by breathing, using gas sensing technology developed by a Cambridge spin-out.

A sensing system developed at Cambridge is being commercialised in the UK for use in rapid, low-cost DNA sequencing, which would make the prediction and diagnosis of disease more efficient, and individualised treatment more affordable.